306 related articles for article (PubMed ID: 21330447)
41. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat.
Lee JM; Trauner M; Soroka CJ; Stieger B; Meier PJ; Boyer JL
Gastroenterology; 2000 Jan; 118(1):163-72. PubMed ID: 10611165
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
[TBL] [Abstract][Full Text] [Related]
43. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.
Liu Y; Binz J; Numerick MJ; Dennis S; Luo G; Desai B; MacKenzie KI; Mansfield TA; Kliewer SA; Goodwin B; Jones SA
J Clin Invest; 2003 Dec; 112(11):1678-87. PubMed ID: 14623915
[TBL] [Abstract][Full Text] [Related]
44. Liver receptor homolog 1 transcriptionally regulates human bile salt export pump expression.
Song X; Kaimal R; Yan B; Deng R
J Lipid Res; 2008 May; 49(5):973-84. PubMed ID: 18270374
[TBL] [Abstract][Full Text] [Related]
45. Clinical application of transcriptional activators of bile salt transporters.
Baghdasaryan A; Chiba P; Trauner M
Mol Aspects Med; 2014 Jun; 37(100):57-76. PubMed ID: 24333169
[TBL] [Abstract][Full Text] [Related]
46. Cholestatic effect of large bilirubin loads and cholestasis protection conferred by cholic acid co-infusion: a molecular and ultrastructural study.
Labori KJ; Arnkvaern K; Bjørnbeth BA; Press CM; Raeder MG
Scand J Gastroenterol; 2002 May; 37(5):585-96. PubMed ID: 12059062
[TBL] [Abstract][Full Text] [Related]
47. Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Hirayama T; Tint GS; Doy M; Shefer S
J Lipid Res; 2005 Feb; 46(2):287-96. PubMed ID: 15576845
[TBL] [Abstract][Full Text] [Related]
48. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.
Cai SY; Gautam S; Nguyen T; Soroka CJ; Rahner C; Boyer JL
Gastroenterology; 2009 Mar; 136(3):1060-9. PubMed ID: 19027009
[TBL] [Abstract][Full Text] [Related]
49. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
Stieger B
Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
[TBL] [Abstract][Full Text] [Related]
50. Sustained upregulation of sodium taurocholate cotransporting polypeptide and bile salt export pump and downregulation of cholesterol 7α-hydroxylase in the liver of patients with end-stage primary biliary cirrhosis.
Takeyama Y; Kanegae K; Inomata S; Takata K; Tanaka T; Ueda S; Yokoyama K; Morihara D; Nishizawa S; Anan A; Irie M; Iwata K; Shakado S; Sohda T; Sakisaka S
Med Mol Morphol; 2010 Sep; 43(3):134-8. PubMed ID: 20857261
[TBL] [Abstract][Full Text] [Related]
51. Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis.
Mühlfeld A; Kubitz R; Dransfeld O; Häussinger D; Wettstein M
Arch Biochem Biophys; 2003 May; 413(1):32-40. PubMed ID: 12706339
[TBL] [Abstract][Full Text] [Related]
52. Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo.
Zhang G; Sun X; Wen Y; Shi A; Zhang J; Wei Y; Wu X
Eur J Pharmacol; 2020 Oct; 885():173498. PubMed ID: 32841642
[TBL] [Abstract][Full Text] [Related]
53. Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice.
Cui YJ; Aleksunes LM; Tanaka Y; Goedken MJ; Klaassen CD
Toxicol Sci; 2009 Jul; 110(1):47-60. PubMed ID: 19407337
[TBL] [Abstract][Full Text] [Related]
54. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process.
Elferink MG; Olinga P; Draaisma AL; Merema MT; Faber KN; Slooff MJ; Meijer DK; Groothuis GM
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1008-16. PubMed ID: 15205115
[TBL] [Abstract][Full Text] [Related]
55. Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression and enhancing the Nrf2-mediated adaptive response.
Zhang W; Chen L; Feng H; Wang W; Cai Y; Qi F; Tao X; Liu J; Shen Y; Ren X; Chen X; Xu J; Shen Y
Free Radic Biol Med; 2017 Nov; 112():24-35. PubMed ID: 28688954
[TBL] [Abstract][Full Text] [Related]
56. The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity.
Garzel B; Yang H; Zhang L; Huang SM; Polli JE; Wang H
Drug Metab Dispos; 2014 Mar; 42(3):318-22. PubMed ID: 24335466
[TBL] [Abstract][Full Text] [Related]
57. Regulation of hepatic bile acid transporters Ntcp and Bsep expression.
Cheng X; Buckley D; Klaassen CD
Biochem Pharmacol; 2007 Dec; 74(11):1665-76. PubMed ID: 17897632
[TBL] [Abstract][Full Text] [Related]
58. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump.
Plass JR; Mol O; Heegsma J; Geuken M; Faber KN; Jansen PL; Müller M
Hepatology; 2002 Mar; 35(3):589-96. PubMed ID: 11870371
[TBL] [Abstract][Full Text] [Related]
59. Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding.
Kassam A; Miao B; Young PR; Mukherjee R
J Biol Chem; 2003 Mar; 278(12):10028-32. PubMed ID: 12519787
[TBL] [Abstract][Full Text] [Related]
60. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
